Directly to content
  1. Publishing |
  2. Search |
  3. Browse |
  4. Recent items rss |
  5. Open Access |
  6. Jur. Issues |
  7. DeutschClear Cookie - decide language by browser settings

A direct regulatory link between microRNA-137 and SHANK2: implications for neuropsychiatric disorders

de Sena Cortabitarte, Ana ; Berkel, Simone ; Cristian, Flavia-Bianca ; Fischer, Christine ; Rappold, Gudrun A.

In: Journal of Neurodevelopmental Disorders, 10 (2018), Nr. 15. pp. 1-11. ISSN 1866-1955

[img]
Preview
PDF, English
Download (914kB) | Lizenz: Creative Commons LizenzvertragA direct regulatory link between microRNA-137 and SHANK2: implications for neuropsychiatric disorders by de Sena Cortabitarte, Ana ; Berkel, Simone ; Cristian, Flavia-Bianca ; Fischer, Christine ; Rappold, Gudrun A. underlies the terms of Creative Commons Attribution 4.0

Citation of documents: Please do not cite the URL that is displayed in your browser location input, instead use the DOI, URN or the persistent URL below, as we can guarantee their long-time accessibility.

Abstract

Background: Mutations in the SHANK genes, which encode postsynaptic scaffolding proteins, have been linked to a spectrum of neurodevelopmental disorders. The SHANK genes and the schizophrenia-associated microRNA-137 show convergence on several levels, as they are both expressed at the synapse, influence neuronal development, and have a strong link to neurodevelopmental and neuropsychiatric disorders like intellectual disability, autism, and schizophrenia. This compiled evidence raised the question if the SHANKs might be targets of miR-137.

Methods: In silico analysis revealed a putative binding site for microRNA-137 (miR-137) in the SHANK2 3′UTR, while this was not the case for SHANK1 and SHANK3. Luciferase reporter assays were performed by overexpressing wild type and mutated SHANK2-3′UTR and miR-137 in human neuroblastoma cells and mouse primary hippocampal neurons. miR-137 was also overexpressed or inhibited in hippocampal neurons, and Shank2 expression was analyzed by quantitative real-time PCR and Western blot. Additionally, expression levels of experimentally validated miR-137 target genes were analyzed in the dorsolateral prefrontal cortex (DLPFC) of schizophrenia and control individuals using the RNA-Seq data from the CommonMind Consortium.

Results: miR-137 directly targets the 3′UTR of SHANK2 in a site-specific manner. Overexpression of miR-137 in mouse primary hippocampal neurons significantly lowered endogenous Shank2 protein levels without detectable influence on mRNA levels. Conversely, miR-137 inhibition increased Shank2 protein expression, indicating that miR-137 regulates SHANK2 expression by repressing protein translation rather than inducing mRNA degradation. To find out if the miR-137 signaling network is altered in schizophrenia, we compared miR-137 precursor and miR-137 target gene expression in the DLPFC of schizophrenia and control individuals using the CommonMind Consortium RNA sequencing data. Differential expression of 23% (16/69) of known miR-137 target genes was detected in the DLPFC of schizophrenia individuals compared with controls. We propose that in further targets (e.g., SHANK2, as described in this paper) which are not regulated on RNA level, effects may only be detectable on protein level.

Conclusion: Our study provides evidence that a direct regulatory link exists between miR-137 and SHANK2 and supports the finding that miR-137 signaling might be altered in schizophrenia.

Item Type: Article
Journal or Publication Title: Journal of Neurodevelopmental Disorders
Volume: 10
Number: 15
Publisher: Springer
Place of Publication: New York
Date Deposited: 02 May 2018 09:21
Date: 2018
ISSN: 1866-1955
Page Range: pp. 1-11
Faculties / Institutes: Service facilities > Interdisziplinäres Zentrum für Neurowissenschaften > IZN Neurobiologie
Medizinische Fakultät Heidelberg > Institut für Humangenetik
Subjects: 610 Medical sciences Medicine
About | FAQ | Contact | Imprint |
OA-LogoDINI certificate 2013Logo der Open-Archives-Initiative